Kyverna Therapeutics, Inc. KYTX Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Kyverna Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kyverna Therapeutics, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kyverna Therapeutics, Inc.'s current ratio?
- Kyverna Therapeutics, Inc. (KYTX) reported current ratio of 8.1× in Q1 2026.
- How has Kyverna Therapeutics, Inc.'s current ratio changed year-over-year?
- Kyverna Therapeutics, Inc.'s current ratio increased by 9.5% year-over-year, from 7.4× to 8.1×.
- What is the long-term trend for Kyverna Therapeutics, Inc.'s current ratio?
- Over 2 years (2023 to 2025), Kyverna Therapeutics, Inc.'s current ratio has grown at a 59.3% compound annual growth rate (CAGR), from 3.1× to 7.8×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.